Inside Ainos (Nasdaq: AIMD): Jack Lu on AI Nose Tech, VELDONA® & the Future of Digital Health
May. 1, 2025
Headquartered in San Diego, California, Ainos, Inc. develops disruptive medical and healthcare solutions based on its proprietary AI Nose and VELDONA® technologies. The name "Ainos" combines "AI" and "Nose" to signify Ainos' commitment to enabling AI with the ability to smell and individuals to live healthier. Ainos' clinical-stage product pipeline includes AI-driven, telehealth-friendly POCT solutions powered by AI Nose, VELDONA® human and animal oral therapeutics, and human orphan drugs.
Ainos, Inc. is a client of RedChip. Visit www.redchip.com/stocks/aimd to learn more.
